242 related articles for article (PubMed ID: 16004819)
1. [Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis].
Zhou S; Liu C; Wu SM; Wu RL
Ai Zheng; 2005 Jul; 24(7):874-9. PubMed ID: 16004819
[TBL] [Abstract][Full Text] [Related]
2. [Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer].
Xue S; Li SX; Wu ZS; Wang XN; Wu Q; Yang F
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):524-8. PubMed ID: 20021962
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance].
Gou XX; Jin F; Chen HX; Wu WL; Chen L; Zeng Y
Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1264-7. PubMed ID: 20646600
[TBL] [Abstract][Full Text] [Related]
4. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
[TBL] [Abstract][Full Text] [Related]
5. Prognostic values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer patients.
Puzovic V; Brcic I; Ranogajec I; Jakic-Razumovic J
Neoplasma; 2014; 61(4):439-46. PubMed ID: 24645837
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
7. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma.
Ishibashi Y; Matsumoto T; Niwa M; Suzuki Y; Omura N; Hanyu N; Nakada K; Yanaga K; Yamada K; Ohkawa K; Kawakami M; Urashima M
Cancer; 2004 Nov; 101(9):1994-2000. PubMed ID: 15372476
[TBL] [Abstract][Full Text] [Related]
8. [Expressions and significances of CD147, OPN and MMP-2 in oral squamous cell carcinoma].
Zhang C; Man DP; Ma SM; Cao SW; Li DW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):683-6. PubMed ID: 23230738
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].
Zhang B; Liu YX; Cao WF; Cao XC; Ning LS; Hao XS
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):471-6. PubMed ID: 19035119
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
[TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of adhesive molecule CD44v6 in breast invasive ductal carcinoma].
Lian ZQ; Yang MT; Hou JH; Luo RZ; Wang X; Tang J
Ai Zheng; 2006 Oct; 25(10):1291-5. PubMed ID: 17059779
[TBL] [Abstract][Full Text] [Related]
12. Tumor grade and matrix metalloproteinase 2 expression in stromal fibroblasts help to stratify the high-risk group of patients with early breast cancer identified on the basis of st Gallen recommendations.
Niemiec J; Adamczyk A; Małecki K; Ambicka A; Ryś J
Clin Breast Cancer; 2013 Apr; 13(2):119-28. PubMed ID: 23375518
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
Sullu Y; Demirag GG; Yildirim A; Karagoz F; Kandemir B
Pathol Res Pract; 2011 Dec; 207(12):747-53. PubMed ID: 22030137
[TBL] [Abstract][Full Text] [Related]
14. Markers of progression and invasion in short term follow up of untreated breast cancer patients.
Rabi ZA; Todorović-Raković N; Vujasinović T; Milovanović J; Nikolić-Vukosavljević D
Cancer Biomark; 2015; 15(6):745-54. PubMed ID: 26406416
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
[TBL] [Abstract][Full Text] [Related]
17. HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection.
Li Y; Xu J; Chen L; Zhong WD; Zhang Z; Mi L; Zhang Y; Liao CG; Bian HJ; Jiang JL; Yang XM; Li XY; Fan CM; Zhu P; Fu L; Chen ZN
Histopathology; 2009 May; 54(6):677-87. PubMed ID: 19438743
[TBL] [Abstract][Full Text] [Related]
18. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
Liu C; Zhou S; Ke CS; Li NP; Wu RL
Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients.
Du ZM; Hu CF; Shao Q; Huang MY; Kou CW; Zhu XF; Zeng YX; Shao JY
Int J Cancer; 2009 Oct; 125(8):1832-41. PubMed ID: 19582878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
